European Union

2019: USTR takes aim at European countries over pharmaceutical pricing and reimbursement policies

On 29 March 2019, the Office of the United States Trade Representative (USTR) published its 2019 National Trade Estimates Report on Foreign Trade Barriers (NTE). Every year, the USTR is tasked with submitting to the “President, the Senate Finance Committee, and appropriate committees in the House of Representatives, an annual report on significant foreign trade …

2019: USTR takes aim at European countries over pharmaceutical pricing and reimbursement policies Read More »

Position of the European Union relating to World Health Organization negotiations on cancer

On 2nd May 2017, the European Commission responded to KEI Europe’s letter (31st March 2017) requesting the European Union to “support a WHO resolution on cancer that would provide the organization a mandate to conduct a feasibility study of creating a multi-country push and pull fund for cancer R&D predicated upon the principle of the …

Position of the European Union relating to World Health Organization negotiations on cancer Read More »

8 March 2017 – Statement of the European Union – HRC 34 – Panel on Access to Medicines

On 8 March 2017, the European Union (EU) delivered the following statement to the Human Rights Council’s panel discussion on Access to Medicines. As the Human Right Council imposed a strict two minute limit on interventions, the EU was not able to raise the following two questions contained at the end of its intervention. I …

8 March 2017 – Statement of the European Union – HRC 34 – Panel on Access to Medicines Read More »